Arcadia Biosciences, Inc. (RKDA) financial statements (2021 and earlier)

Company profile

Business Address 202 COUSTEAU PLACE
DAVIS, 95618
State of Incorp. DE
Fiscal Year End December 31
SIC 01 - Agricultural Production Crops (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments262522135150
Cash and cash equivalents148129224
Short-term investments12171044926
Receivables110111
Inventory, net of allowances, customer advances and progress billings420000
Inventory420000
Deferred costs 00   
Other undisclosed current assets101111
Total current assets:322823155252
Noncurrent Assets
Inventory, Noncurrent301112
Operating lease, right-of-use asset62
Property, plant and equipment420011
Long-term investments and receivables    220
Long-term investments    220
Intangible assets, net (including goodwill)1     
Goodwill0     
Intangible assets, net (excluding goodwill)0     
Restricted cash and investments2     
Other noncurrent assets000000
Total noncurrent assets:16412422
TOTAL ASSETS:473324175774
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:453222
Accounts payable100000
Accrued liabilities111000
Employee-related liabilities111111
Interest and dividends payable    00
Other undisclosed accounts payable and accrued liabilities121101
Deferred revenue00
Debt11    
Due to related parties000000
Deferred revenue and credits111
Contract with customer, liability0
Other liabilities000   
Other undisclosed current liabilities1     
Total current liabilities:663433
Noncurrent Liabilities
Long-term debt and lease obligation72  2525
Long-term debt, excluding current maturities20  2525
Operating lease, liability51
Liabilities, other than long-term debt223566
Deferred revenue and credits233
Other liabilities223333
Other undisclosed noncurrent liabilities3155   
Total noncurrent liabilities:1219853131
Total liabilities:19241193434
Stockholders' equity
Stockholders' equity attributable to parent2881382240
Common stock000000
Additional paid in capital239215191175174172
Accumulated other comprehensive income (loss) 0 (0)(0)(0)
Accumulated deficit(212)(207)(178)(167)(152)(132)
Stockholders' equity attributable to noncontrolling interest11    
Total stockholders' equity:2981382240
TOTAL LIABILITIES AND EQUITY:473324175774

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues811435
Revenue, net435
Cost of revenue
(Cost of Goods and Services Sold)
(4)(0)(0)(0)(1)(1)
Gross profit:411435
Operating expenses(21)(21)(18)(18)(22)(21)
Other undisclosed operating income400011
Operating loss:(13)(19)(17)(14)(19)(16)
Nonoperating income
(Other Nonoperating income)
100001
Interest and debt expense(1)(0) (2)(1)(3)
Loss from continuing operations before equity method investments, income taxes:(13)(19)(16)(16)(20)(18)
Other undisclosed income (loss) from continuing operations before income taxes7(10)3   
Loss from continuing operations before income taxes:(6)(29)(13)(16)(20)(18)
Income tax expense (benefit)0(0)(0)(0)(0)(0)
Net loss:(6)(29)(13)(16)(20)(18)
Net income attributable to noncontrolling interest10    
Net loss attributable to parent:(5)(29)(13)(16)(20)(18)
Preferred stock dividends and other adjustments     (3)
Other undisclosed net loss available to common stockholders, basic     (0)
Net loss available to common stockholders, diluted:(5)(29)(13)(16)(20)(21)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(6)(29)(13)(16)(20)(18)
Other comprehensive income (loss)(0)0 00(0)
Comprehensive loss:(6)(29)(13)(16)(20)(18)
Comprehensive income, net of tax, attributable to noncontrolling interest10    
Other undisclosed comprehensive loss, net of tax, attributable to parent     (3)
Comprehensive loss, net of tax, attributable to parent:(5)(29)(13)(16)(20)(21)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: